Encorafenib

HealthData.Gov

Updated Oct 29, 2026

About this dataset

BRAFTOVI (encorafenib) is an oral prescription drug manufactured by Array BioPharma Inc., available as capsules in 75mg strength (50mg discontinued). Approved under NDA210496, it's used for certain cancers. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

HTML
Encorafenib
Access the FDA dataset for Encorafenib — ANDA 210496 submitted by Mylan Institutional LLC
Modified Apr 29, 2026
Open link: Encorafenib

Prototype by Datopian · not an official government website · data from data.virginia.gov